Pharming Group NV banner

Pharming Group NV
AEX:PHARM

Watchlist Manager
Pharming Group NV Logo
Pharming Group NV
AEX:PHARM
Watchlist
Price: 1.294 EUR -2.41% Market Closed
Market Cap: €907.6m

Intrinsic Value

The intrinsic value of one PHARM stock under the Base Case scenario is 1.765 EUR. Compared to the current market price of 1.294 EUR, Pharming Group NV is Undervalued by 27%.

PHARM Intrinsic Value
1.765 EUR
Undervaluation 27%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Pharming Group NV

What is Valuation History?
Ask AI Assistant
What other research platforms think about PHARM?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is PHARM valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Pharming Group NV.

Explain Valuation
Alternatives to PHARM

Wall St
Price Targets

Dividends

Pharming Group NV
does not pay dividends
Shareholder Yield

Competitive Landscape

What is the Intrinsic Value of one PHARM stock?

The intrinsic value of one PHARM stock under the Base Case scenario is 1.765 EUR.

Is PHARM stock undervalued or overvalued?

Compared to the current market price of 1.294 EUR, Pharming Group NV is Undervalued by 27%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett